Format

Send to

Choose Destination
Clin Microbiol Infect. 2019 Aug 8. pii: S1198-743X(19)30416-1. doi: 10.1016/j.cmi.2019.07.024. [Epub ahead of print]

Reporting infectious complications in haematology clinical trials should be improved.

Author information

1
Assistance Publique-Hopitaux de Paris, Henri Mondor Hospital, Haematology Department, and University Paris-Est Créteil, Créteil, France. Electronic address: catherine.cordonnier@aphp.fr.
2
Department of Haematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Charlottenstrasse 72, 14467, Potsdam, Germany.
3
Pediatric Haematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
4
Department of Cellular Therapy and Allogeneic Stem Cell transplantation, Karolinska University Hospital, and Division of Haematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

KEYWORDS:

Hematological malignancies; Infections; Infectious complications; New drugs; Prospective trials

PMID:
31401173
DOI:
10.1016/j.cmi.2019.07.024

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center